Global Custom Antibody Market: Industry Analysis and Forecast (2019-2026), By Service, Type, Source, Research area, End-user and Region.

Global Custom Antibody Market: Industry Analysis and Forecast (2019-2026), By Service, Type, Source, Research area, End-user and Region.

Market Scenario

Global Custom Antibody Market was valued US$ XX Mn in 2018 and is expected to reach US$ 619.11 Mn by 2026, at a CAGR of around XX % during a forecast period. Global Custom Antibody Market Custom antibody offers high specificity and selectivity, these antibodies are easy to produce as compared to other antibodies and are therefore the preferred choice in all types of research studies. The report covers all the trends and technologies playing a major role in the growth of the Custom Antibody market during the forecast period. It highlights the drivers, restraints, and opportunities expected to influence the market growth during 2019-2026. The global custom antibody market is being driven by factors such as increasing research activity in the life sciences industry along with increasing associations between industry and academic centers are driving the growth of the custom antibody market during the forecast period. However, the high cost of initial investment for the development of custom antibodies along with strict regulatory compliance is a major factor restraining custom antibody market growth during the forecast period. Additionally, increasing demand for custom medicine and a rise in demand for antibody-based therapeutics is creating profitable opportunities in the market attracting major global players boosting the growth of the custom antibody market globally. Based on type, the monoclonal antibodies segment is valued at US$ XX Mn in 2018 and is expected to reach US$ XX Mn by 2026 at a CAGR of XX% during the forecast period. Because monoclonal antibody provides high specificity and selectivity compared to other antibodies Based on the research area, the oncology segment is expected for the largest share of the custom antibodies market during the forecast period. This large share is attributed to the fact that cancer is one of the leading causes of death globally, which has driven the focus on its early detection and treatment. North America region is expected to grow at a XX % rate of CAGR during the forecast period owing to increasing investments in the development of structure-based drug designs, growing research in the fields of genomics and proteomics. And also rising demand for high-quality research tools for data reproducibility, increasing focus on developing antibody-based therapeutics, and the presence of a large number of global players in this region. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Custom Antibody Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in Global Custom Antibody Market.

Scope of the Global Custom Antibody Market

Global Custom Antibody Market, By Service

• Antibody Development o Antigen Preparation o Immunization & Hybridoma Production o Antibody Characterization • Antibody Production & Purification • Antibody Fragmentation & Labelling

Global Custom Antibody Market, By Type

• Monoclonal Antibodies • Polyclonal Antibodies • Recombinant Antibodies • Others

Global Custom Antibody Market, By Source

• Mice • Rabbit • Other

Global Custom Antibody Market, By Research area

• Oncology • Infectious Diseases • Immunology • Neurobiology • Stem Cell • Cardiovascular Diseases • Others

Global Custom Antibody Market, By End-user

• Pharmaceutical & Biotechnology Companies • Academic & Research Institutes • Contract Research Organizations Global Custom Antibody Market, By Region • North America • Europe • Asia Pacific • Middle East & Africa • South America

Kay players operating in the Global Custom Antibody Market

• Thermo Fisher Scientific Inc. • Genscript Biotech Corporation • Abcam plc • Rockland Immunochemicals Inc. • Creative Biolabs Inc. • RayBiotech Inc. • Covance Inc • Bio-Rad Laboratories, Inc. • Merck Group • Cell Signaling Technology, Inc. • Agilent Technologies, Inc. • BioLegend, Inc. • ProMab Biotechnologies Global Microcarrier Market

Table of Contents

Global Custom Antibody Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Custom Antibody Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Custom Antibody Market Analysis and Forecast 6.1. Global Custom Antibody Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Custom Antibody Market Analysis and Forecast, by Service 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Custom Antibody Market Value Share Analysis, by Service 7.4. Global Custom Antibody Market Size (US$ Mn) Forecast, by Service 7.5. Global Custom Antibody Market Analysis, by Service 7.6. Global Custom Antibody Market Attractiveness Analysis, by Service 8. Global Custom Antibody Market Analysis and Forecast, by End User 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Custom Antibody Market Value Share Analysis, by End User 8.4. Global Custom Antibody Market Size (US$ Mn) Forecast, by End User 8.5. Global Custom Antibody Market Analysis, by End User 8.6. Global Custom Antibody Market Attractiveness Analysis, by End User 9. Global Custom Antibody Market Analysis and Forecast, by Type 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Custom Antibody Market Value Share Analysis, by Type 9.4. Global Custom Antibody Market Size (US$ Mn) Forecast, by Type 9.5. Global Custom Antibody Market Analysis, by Type 9.6. Global Custom Antibody Market Attractiveness Analysis, by Type 10. Global Custom Antibody Market Analysis and Forecast, by Source 10.1. Introduction and Definition 10.2. Key Findings 10.3. Global Custom Antibody Market Value Share Analysis, by Source 10.4. Global Custom Antibody Market Size (US$ Mn) Forecast, by Source 10.5. Global Custom Antibody Market Analysis, by Source 10.6. Global Custom Antibody Market Attractiveness Analysis, by Source 11. Global Custom Antibody Market Analysis and Forecast, by Research area 11.1. Introduction and Definition 11.2. Key Findings 11.3. Global Custom Antibody Market Value Share Analysis, by Research area 11.4. Global Custom Antibody Market Size (US$ Mn) Forecast, by Research area 11.5. Global Custom Antibody Market Analysis, by Research area 11.6. Global Custom Antibody Market Attractiveness Analysis, by Research area 12. Global Custom Antibody Market Analysis, by Region 12.1. Global Custom Antibody Market Value Share Analysis, by Region 12.2. Global Custom Antibody Market Size (US$ Mn) Forecast, by Region 12.3. Global Custom Antibody Market Attractiveness Analysis, by Region 13. North America Custom Antibody Market Analysis 13.1. Key Findings 13.2. North America Custom Antibody Market Overview 13.3. North America Custom Antibody Market Value Share Analysis, by Service 13.4. North America Custom Antibody Market Forecast, by Service 13.4.1. Antibody Development 13.4.1.1. Antigen Preparation 13.4.1.2. Immunization & Hybridoma Production 13.4.1.3. Antibody Characterization 13.4.2. Antibody Production & Purification 13.4.3. Antibody Fragmentation & Labelling 13.5. North America Custom Antibody Market Value Share Analysis, by End User 13.6. North America Custom Antibody Market Forecast, by End User 13.6.1. Pharmaceutical & Biotechnology Companies 13.6.2. Academic & Research Institutes 13.6.3. Contract Research Organizations 13.7. North America Custom Antibody Market Value Share Analysis, by Type 13.8. North America Custom Antibody Market Forecast, by Type 13.8.1. Monoclonal Antibodies 13.8.2. Polyclonal Antibodies 13.8.3. Recombinant Antibodies 13.8.4. Others 13.9. North America Custom Antibody Market Value Share Analysis, by Source 13.10. North America Custom Antibody Market Forecast, by Source 13.10.1. Mice 13.10.2. Rabbit 13.10.3. Other 13.11. North America Custom Antibody Market Value Share Analysis, by Research area 13.12. North America Custom Antibody Market Forecast, by Research area 13.12.1. Oncology 13.12.2. Infectious Diseases 13.12.3. Immunology 13.12.4. Neurobiology 13.12.5. Stem Cell 13.12.6. Cardiovascular Diseases 13.12.7. Others 13.13. North America Custom Antibody Market Value Share Analysis, by Country 13.14. North America Custom Antibody Market Forecast, by Country 13.14.1. U.S. 13.14.2. Canada 13.15. North America Custom Antibody Market Analysis, by Country 13.16. U.S. Custom Antibody Market Forecast, by Service 13.16.1. Antibody Development 13.16.1.1. Antigen Preparation 13.16.1.2. Immunization & Hybridoma Production 13.16.1.3. Antibody Characterization 13.16.2. Antibody Production & Purification 13.16.3. Antibody Fragmentation & Labelling 13.17. U.S. Custom Antibody Market Forecast, by End User 13.17.1. Pharmaceutical & Biotechnology Companies 13.17.2. Academic & Research Institutes 13.17.3. Contract Research Organizations 13.18. U.S. Custom Antibody Market Forecast, by Type 13.18.1. Monoclonal Antibodies 13.18.2. Polyclonal Antibodies 13.18.3. Recombinant Antibodies 13.18.4. Others 13.19. U.S. Custom Antibody Market Forecast, by Source 13.19.1. Mice 13.19.2. Rabbit 13.19.3. Other 13.20. U.S. Custom Antibody Market Forecast, by Research area 13.20.1. Oncology 13.20.2. Infectious Diseases 13.20.3. Immunology 13.20.4. Neurobiology 13.20.5. Stem Cell 13.20.6. Cardiovascular Diseases 13.20.7. Others 13.21. Canada Custom Antibody Market Forecast, by Service 13.21.1. Antibody Development 13.21.1.1. Antigen Preparation 13.21.1.2. Immunization & Hybridoma Production 13.21.1.3. Antibody Characterization 13.21.2. Antibody Production & Purification 13.21.3. Antibody Fragmentation & Labelling 13.22. Canada Custom Antibody Market Forecast, by End User 13.22.1. Pharmaceutical & Biotechnology Companies 13.22.2. Academic & Research Institutes 13.22.3. Contract Research Organizations 13.23. Canada Custom Antibody Market Forecast, by Type 13.23.1. Monoclonal Antibodies 13.23.2. Polyclonal Antibodies 13.23.3. Recombinant Antibodies 13.23.4. Others 13.24. Canada Custom Antibody Market Forecast, by Source 13.24.1. Mice 13.24.2. Rabbit 13.24.3. Other 13.25. Canada Custom Antibody Market Forecast, by Research area 13.25.1. Oncology 13.25.2. Infectious Diseases 13.25.3. Immunology 13.25.4. Neurobiology 13.25.5. Stem Cell 13.25.6. Cardiovascular Diseases 13.25.7. Others 13.26. North America Custom Antibody Market Attractiveness Analysis 13.26.1. By Service 13.26.2. By End User 13.26.3. By Type 13.26.4. By Source 13.26.5. By Research area 13.27. PEST Analysis 13.28. Key Trends 13.29. Key Developments 14. Europe Custom Antibody Market Analysis 14.1. Key Findings 14.2. Europe Custom Antibody Market Overview 14.3. Europe Custom Antibody Market Value Share Analysis, by Service 14.4. Europe Custom Antibody Market Forecast, by Service 14.4.1. Antibody Development 14.4.1.1. Antigen Preparation 14.4.1.2. Immunization & Hybridoma Production 14.4.1.3. Antibody Characterization 14.4.2. Antibody Production & Purification 14.4.3. Antibody Fragmentation & Labelling 14.5. Europe Custom Antibody Market Value Share Analysis, by End User 14.6. Europe Custom Antibody Market Forecast, by End User 14.6.1. Pharmaceutical & Biotechnology Companies 14.6.2. Academic & Research Institutes 14.6.3. Contract Research Organizations 14.7. Europe Custom Antibody Market Value Share Analysis, by Type 14.8. Europe Custom Antibody Market Forecast, by Type 14.8.1. Monoclonal Antibodies 14.8.2. Polyclonal Antibodies 14.8.3. Recombinant Antibodies 14.8.4. Others 14.9. Europe Custom Antibody Market Value Share Analysis, by Source 14.10. Europe Custom Antibody Market Forecast, by Source 14.10.1. Mice 14.10.2. Rabbit 14.10.3. Other 14.11. Europe Custom Antibody Market Value Share Analysis, by Research area 14.12. Europe Custom Antibody Market Forecast, by Research area 14.12.1. Oncology 14.12.2. Infectious Diseases 14.12.3. Immunology 14.12.4. Neurobiology 14.12.5. Stem Cell 14.12.6. Cardiovascular Diseases 14.12.7. Others 14.13. Europe Custom Antibody Market Value Share Analysis, by Country 14.14. Europe Custom Antibody Market Forecast, by Country 14.14.1. Germany 14.14.2. U.K. 14.14.3. France 14.14.4. Italy 14.14.5. Spain 14.14.6. Rest of Europe 14.15. Europe Custom Antibody Market Analysis, by Country 14.16. Germany Custom Antibody Market Forecast, by Service 14.16.1. Antibody Development 14.16.1.1. Antigen Preparation 14.16.1.2. Immunization & Hybridoma Production 14.16.1.3. Antibody Characterization 14.16.2. Antibody Production & Purification 14.16.3. Antibody Fragmentation & Labelling 14.17. Germany Custom Antibody Market Forecast, by End User 14.17.1. Pharmaceutical & Biotechnology Companies 14.17.2. Academic & Research Institutes 14.17.3. Contract Research Organizations 14.18. Germany Custom Antibody Market Forecast, by Type 14.18.1. Monoclonal Antibodies 14.18.2. Polyclonal Antibodies 14.18.3. Recombinant Antibodies 14.18.4. Others 14.19. Germany Custom Antibody Market Forecast, by Source 14.19.1. Mice 14.19.2. Rabbit 14.19.3. Other 14.20. Germany Custom Antibody Market Forecast, by Research area 14.20.1. Oncology 14.20.2. Infectious Diseases 14.20.3. Immunology 14.20.4. Neurobiology 14.20.5. Stem Cell 14.20.6. Cardiovascular Diseases 14.20.7. Others 14.21. U.K. Custom Antibody Market Forecast, by Service 14.21.1. Antibody Development 14.21.1.1. Antigen Preparation 14.21.1.2. Immunization & Hybridoma Production 14.21.1.3. Antibody Characterization 14.21.2. Antibody Production & Purification 14.21.3. Antibody Fragmentation & Labelling 14.22. U.K. Custom Antibody Market Forecast, by End User 14.22.1. Pharmaceutical & Biotechnology Companies 14.22.2. Academic & Research Institutes 14.22.3. Contract Research Organizations 14.23. U.K. Custom Antibody Market Forecast, by Type 14.23.1. Monoclonal Antibodies 14.23.2. Polyclonal Antibodies 14.23.3. Recombinant Antibodies 14.23.4. Others 14.24. U.K. Custom Antibody Market Forecast, by Source 14.24.1. Mice 14.24.2. Rabbit 14.24.3. Other 14.25. U.K. Custom Antibody Market Forecast, by Research area 14.25.1. Oncology 14.25.2. Infectious Diseases 14.25.3. Immunology 14.25.4. Neurobiology 14.25.5. Stem Cell 14.25.6. Cardiovascular Diseases 14.25.7. Others 14.26. France Custom Antibody Market Forecast, by Service 14.26.1. Antibody Development 14.26.1.1. Antigen Preparation 14.26.1.2. Immunization & Hybridoma Production 14.26.1.3. Antibody Characterization 14.26.2. Antibody Production & Purification 14.26.3. Antibody Fragmentation & Labelling 14.27. France Custom Antibody Market Forecast, by End User 14.27.1. Pharmaceutical & Biotechnology Companies 14.27.2. Academic & Research Institutes 14.27.3. Contract Research Organizations 14.28. France Custom Antibody Market Forecast, by Type 14.28.1. Monoclonal Antibodies 14.28.2. Polyclonal Antibodies 14.28.3. Recombinant Antibodies 14.28.4. Others 14.29. France Custom Antibody Market Forecast, by Source 14.29.1. Mice 14.29.2. Rabbit 14.29.3. Other 14.30. France Custom Antibody Market Forecast, by Research area 14.30.1. Oncology 14.30.2. Infectious Diseases 14.30.3. Immunology 14.30.4. Neurobiology 14.30.5. Stem Cell 14.30.6. Cardiovascular Diseases 14.30.7. Others 14.31. Italy Custom Antibody Market Forecast, by Service 14.31.1. Antibody Development 14.31.1.1. Antigen Preparation 14.31.1.2. Immunization & Hybridoma Production 14.31.1.3. Antibody Characterization 14.31.2. Antibody Production & Purification 14.31.3. Antibody Fragmentation & Labelling 14.32. Italy Custom Antibody Market Forecast, by End User 14.32.1. Pharmaceutical & Biotechnology Companies 14.32.2. Academic & Research Institutes 14.32.3. Contract Research Organizations 14.33. Italy Custom Antibody Market Forecast, by Type 14.33.1. Monoclonal Antibodies 14.33.2. Polyclonal Antibodies 14.33.3. Recombinant Antibodies 14.33.4. Others 14.34. Italy Custom Antibody Market Forecast, by Source 14.34.1. Mice 14.34.2. Rabbit 14.34.3. Other 14.35. Italy Custom Antibody Market Forecast, by Research area 14.35.1. Oncology 14.35.2. Infectious Diseases 14.35.3. Immunology 14.35.4. Neurobiology 14.35.5. Stem Cell 14.35.6. Cardiovascular Diseases 14.35.7. Others 14.36. Spain Custom Antibody Market Forecast, by Service 14.36.1. Antibody Development 14.36.1.1. Antigen Preparation 14.36.1.2. Immunization & Hybridoma Production 14.36.1.3. Antibody Characterization 14.36.2. Antibody Production & Purification 14.36.3. Antibody Fragmentation & Labelling 14.37. Spain Custom Antibody Market Forecast, by End User 14.37.1. Pharmaceutical & Biotechnology Companies 14.37.2. Academic & Research Institutes 14.37.3. Contract Research Organizations 14.38. Spain Custom Antibody Market Forecast, by Type 14.38.1. Monoclonal Antibodies 14.38.2. Polyclonal Antibodies 14.38.3. Recombinant Antibodies 14.38.4. Others 14.39. Spain Custom Antibody Market Forecast, by Source 14.39.1. Mice 14.39.2. Rabbit 14.39.3. Other 14.40. Spain Custom Antibody Market Forecast, by Research area 14.40.1. Oncology 14.40.2. Infectious Diseases 14.40.3. Immunology 14.40.4. Neurobiology 14.40.5. Stem Cell 14.40.6. Cardiovascular Diseases 14.40.7. Others 14.41. Rest of Europe Custom Antibody Market Forecast, by Service 14.41.1. Antibody Development 14.41.1.1. Antigen Preparation 14.41.1.2. Immunization & Hybridoma Production 14.41.1.3. Antibody Characterization 14.41.2. Antibody Production & Purification 14.41.3. Antibody Fragmentation & Labelling 14.42. Rest of Europe Custom Antibody Market Forecast, by End User 14.42.1. Pharmaceutical & Biotechnology Companies 14.42.2. Academic & Research Institutes 14.42.3. Contract Research Organizations 14.43. Rest of Europe Custom Antibody Market Forecast, by Type 14.43.1. Monoclonal Antibodies 14.43.2. Polyclonal Antibodies 14.43.3. Recombinant Antibodies 14.43.4. Others 14.44. Rest Of Europe Custom Antibody Market Forecast, by Source 14.44.1. Mice 14.44.2. Rabbit 14.44.3. Other 14.45. Rest Of Europe Custom Antibody Market Forecast, by Research area 14.45.1. Oncology 14.45.2. Infectious Diseases 14.45.3. Immunology 14.45.4. Neurobiology 14.45.5. Stem Cell 14.45.6. Cardiovascular Diseases 14.45.7. Others 14.46. Europe Custom Antibody Market Attractiveness Analysis 14.46.1. By Service 14.46.2. By End User 14.46.3. By Type 14.46.4. By Source 14.46.5. By Research area 14.47. PEST Analysis 14.48. Key Trends 14.49. Key Developments 15. Asia Pacific Custom Antibody Market Analysis 15.1. Key Findings 15.2. Asia Pacific Custom Antibody Market Overview 15.3. Asia Pacific Custom Antibody Market Value Share Analysis, by Service 15.4. Asia Pacific Custom Antibody Market Forecast, by Service 15.4.1. Antibody Development 15.4.1.1. Antigen Preparation 15.4.1.2. Immunization & Hybridoma Production 15.4.1.3. Antibody Characterization 15.4.2. Antibody Production & Purification 15.4.3. Antibody Fragmentation & Labelling 15.5. Asia Pacific Custom Antibody Market Value Share Analysis, by End User 15.6. Asia Pacific Custom Antibody Market Forecast, by End User 15.6.1. Pharmaceutical & Biotechnology Companies 15.6.2. Academic & Research Institutes 15.6.3. Contract Research Organizations 15.7. Asia Pacific Custom Antibody Market Value Share Analysis, by Type 15.8. Asia Pacific Custom Antibody Market Forecast, by Type 15.8.1. Monoclonal Antibodies 15.8.2. Polyclonal Antibodies 15.8.3. Recombinant Antibodies 15.8.4. Others 15.9. Asia Pacific Custom Antibody Market Value Share Analysis, by Source 15.10. Asia Pacific Custom Antibody Market Forecast, by Source 15.10.1. Mice 15.10.2. Rabbit 15.10.3. Other 15.11. Asia Pacific Custom Antibody Market Value Share Analysis, by Research area 15.12. Asia Pacific Custom Antibody Market Forecast, by Research area 15.12.1. Oncology 15.12.2. Infectious Diseases 15.12.3. Immunology 15.12.4. Neurobiology 15.12.5. Stem Cell 15.12.6. Cardiovascular Diseases 15.12.7. Others 15.13. Asia Pacific Custom Antibody Market Value Share Analysis, by Country 15.14. Asia Pacific Custom Antibody Market Forecast, by Country 15.14.1. China 15.14.2. India 15.14.3. Japan 15.14.4. ASEAN 15.14.5. Rest of Asia Pacific 15.15. Asia Pacific Custom Antibody Market Analysis, by Country 15.16. China Custom Antibody Market Forecast, by Service 15.16.1. Antibody Development 15.16.1.1. Antigen Preparation 15.16.1.2. Immunization & Hybridoma Production 15.16.1.3. Antibody Characterization 15.16.2. Antibody Production & Purification 15.16.3. Antibody Fragmentation & Labelling 15.17. China Custom Antibody Market Forecast, by End User 15.17.1. Pharmaceutical & Biotechnology Companies 15.17.2. Academic & Research Institutes 15.17.3. Contract Research Organizations 15.18. China Custom Antibody Market Forecast, by Type 15.18.1. Monoclonal Antibodies 15.18.2. Polyclonal Antibodies 15.18.3. Recombinant Antibodies 15.18.4. Others 15.19. China Custom Antibody Market Forecast, by Source 15.19.1. Mice 15.19.2. Rabbit 15.19.3. Other 15.20. China Custom Antibody Market Forecast, by Research area 15.20.1. Oncology 15.20.2. Infectious Diseases 15.20.3. Immunology 15.20.4. Neurobiology 15.20.5. Stem Cell 15.20.6. Cardiovascular Diseases 15.20.7. Others 15.21. India Custom Antibody Market Forecast, by Service 15.21.1. Antibody Development 15.21.1.1. Antigen Preparation 15.21.1.2. Immunization & Hybridoma Production 15.21.1.3. Antibody Characterization 15.21.2. Antibody Production & Purification 15.21.3. Antibody Fragmentation & Labelling 15.22. India Custom Antibody Market Forecast, by End User 15.22.1. Pharmaceutical & Biotechnology Companies 15.22.2. Academic & Research Institutes 15.22.3. Contract Research Organizations 15.23. India Custom Antibody Market Forecast, by Type 15.23.1. Monoclonal Antibodies 15.23.2. Polyclonal Antibodies 15.23.3. Recombinant Antibodies 15.23.4. Others 15.24. India Custom Antibody Market Forecast, by Source 15.24.1. Mice 15.24.2. Rabbit 15.24.3. Other 15.25. India Custom Antibody Market Forecast, by Research area 15.25.1. Oncology 15.25.2. Infectious Diseases 15.25.3. Immunology 15.25.4. Neurobiology 15.25.5. Stem Cell 15.25.6. Cardiovascular Diseases 15.25.7. Others 15.26. Japan Custom Antibody Market Forecast, by Service 15.26.1. Antibody Development 15.26.1.1. Antigen Preparation 15.26.1.2. Immunization & Hybridoma Production 15.26.1.3. Antibody Characterization 15.26.2. Antibody Production & Purification 15.26.3. Antibody Fragmentation & Labelling 15.27. Japan Custom Antibody Market Forecast, by End User 15.27.1. Pharmaceutical & Biotechnology Companies 15.27.2. Academic & Research Institutes 15.27.3. Contract Research Organizations 15.28. Japan Custom Antibody Market Forecast, by Type 15.28.1. Monoclonal Antibodies 15.28.2. Polyclonal Antibodies 15.28.3. Recombinant Antibodies 15.28.4. Others 15.29. Japan Custom Antibody Market Forecast, by Source 15.29.1. Mice 15.29.2. Rabbit 15.29.3. Other 15.30. Japan Custom Antibody Market Forecast, by Research area 15.30.1. Oncology 15.30.2. Infectious Diseases 15.30.3. Immunology 15.30.4. Neurobiology 15.30.5. Stem Cell 15.30.6. Cardiovascular Diseases 15.30.7. Others 15.31. ASEAN Custom Antibody Market Forecast, by Service 15.31.1. Antibody Development 15.31.1.1. Antigen Preparation 15.31.1.2. Immunization & Hybridoma Production 15.31.1.3. Antibody Characterization 15.31.2. Antibody Production & Purification 15.31.3. Antibody Fragmentation & Labelling 15.32. ASEAN Custom Antibody Market Forecast, by End User 15.32.1. Pharmaceutical & Biotechnology Companies 15.32.2. Academic & Research Institutes 15.32.3. Contract Research Organizations 15.33. ASEAN Custom Antibody Market Forecast, by Type 15.33.1. Monoclonal Antibodies 15.33.2. Polyclonal Antibodies 15.33.3. Recombinant Antibodies 15.33.4. Others 15.34. ASEAN Custom Antibody Market Forecast, by Source 15.34.1. Mice 15.34.2. Rabbit 15.34.3. Other 15.35. ASEAN Custom Antibody Market Forecast, by Research area 15.35.1. Oncology 15.35.2. Infectious Diseases 15.35.3. Immunology 15.35.4. Neurobiology 15.35.5. Stem Cell 15.35.6. Cardiovascular Diseases 15.35.7. Others 15.36. Rest of Asia Pacific Custom Antibody Market Forecast, by Service 15.36.1. Antibody Development 15.36.1.1. Antigen Preparation 15.36.1.2. Immunization & Hybridoma Production 15.36.1.3. Antibody Characterization 15.36.2. Antibody Production & Purification 15.36.3. Antibody Fragmentation & Labelling 15.37. Rest of Asia Pacific Custom Antibody Market Forecast, by End User 15.37.1. Pharmaceutical & Biotechnology Companies 15.37.2. Academic & Research Institutes 15.37.3. Contract Research Organizations 15.38. Rest of Asia Pacific Custom Antibody Market Forecast, by Type 15.38.1. Monoclonal Antibodies 15.38.2. Polyclonal Antibodies 15.38.3. Recombinant Antibodies 15.38.4. Others 15.39. Rest of Asia Pacific Custom Antibody Market Forecast, by Source 15.39.1. Mice 15.39.2. Rabbit 15.39.3. Other 15.40. Rest of Asia Pacific Custom Antibody Market Forecast, by Research area 15.40.1. Oncology 15.40.2. Infectious Diseases 15.40.3. Immunology 15.40.4. Neurobiology 15.40.5. Stem Cell 15.40.6. Cardiovascular Diseases 15.40.7. Others 15.41. Asia Pacific Custom Antibody Market Attractiveness Analysis 15.41.1. By Service 15.41.2. By End User 15.41.3. By Type 15.41.4. By Source 15.41.5. By Research area 15.42. PEST Analysis 15.43. Key Trends 15.44. Key Developments 16. Middle East & Africa Custom Antibody Market Analysis 16.1. Key Findings 16.2. Middle East & Africa Custom Antibody Market Overview 16.3. Middle East & Africa Custom Antibody Market Value Share Analysis, by Service 16.4. Middle East & Africa Custom Antibody Market Forecast, by Service 16.4.1. Antibody Development 16.4.1.1. Antigen Preparation 16.4.1.2. Immunization & Hybridoma Production 16.4.1.3. Antibody Characterization 16.4.2. Antibody Production & Purification 16.4.3. Antibody Fragmentation & Labelling 16.5. Middle East & Africa Custom Antibody Market Value Share Analysis, by End User 16.6. Middle East & Africa Custom Antibody Market Forecast, by End User 16.6.1. Pharmaceutical & Biotechnology Companies 16.6.2. Academic & Research Institutes 16.6.3. Contract Research Organizations 16.7. Middle East & Africa Custom Antibody Market Value Share Analysis, by Type 16.8. Middle East & Africa Custom Antibody Market Forecast, by Type 16.8.1. Monoclonal Antibodies 16.8.2. Polyclonal Antibodies 16.8.3. Recombinant Antibodies 16.8.4. Others 16.9. Middle East & Africa Custom Antibody Market Value Share Analysis, by Source 16.10. Middle East & Africa Custom Antibody Market Forecast, by Source 16.10.1. Mice 16.10.2. Rabbit 16.10.3. Other 16.11. Middle East & Africa Custom Antibody Market Value Share Analysis, by Research area 16.12. Middle East & Africa Custom Antibody Market Forecast, by Research area 16.12.1. Oncology 16.12.2. Infectious Diseases 16.12.3. Immunology 16.12.4. Neurobiology 16.12.5. Stem Cell 16.12.6. Cardiovascular Diseases 16.12.7. Others 16.13. Middle East & Africa Custom Antibody Market Value Share Analysis, by Country 16.14. Middle East & Africa Custom Antibody Market Forecast, by Country 16.14.1. GCC 16.14.2. South Africa 16.14.3. Rest of Middle East & Africa 16.15. Middle East & Africa Custom Antibody Market Analysis, by Country 16.16. GCC Custom Antibody Market Forecast, by Service 16.16.1. Antibody Development 16.16.1.1. Antigen Preparation 16.16.1.2. Immunization & Hybridoma Production 16.16.1.3. Antibody Characterization 16.16.2. Antibody Production & Purification 16.16.3. Antibody Fragmentation & Labelling 16.17. GCC Custom Antibody Market Forecast, by End User 16.17.1. Pharmaceutical & Biotechnology Companies 16.17.2. Academic & Research Institutes 16.17.3. Contract Research Organizations 16.18. GCC Custom Antibody Market Forecast, by Type 16.18.1. Monoclonal Antibodies 16.18.2. Polyclonal Antibodies 16.18.3. Recombinant Antibodies 16.18.4. Others 16.19. GCC Custom Antibody Market Forecast, by Source 16.19.1. Mice 16.19.2. Rabbit 16.19.3. Other 16.20. GCC Custom Antibody Market Forecast, by Research area 16.20.1. Oncology 16.20.2. Infectious Diseases 16.20.3. Immunology 16.20.4. Neurobiology 16.20.5. Stem Cell 16.20.6. Cardiovascular Diseases 16.20.7. Others 16.21. South Africa Custom Antibody Market Forecast, by Service 16.21.1. Antibody Development 16.21.1.1. Antigen Preparation 16.21.1.2. Immunization & Hybridoma Production 16.21.1.3. Antibody Characterization 16.21.2. Antibody Production & Purification 16.21.3. Antibody Fragmentation & Labelling 16.22. South Africa Custom Antibody Market Forecast, by End User 16.22.1. Pharmaceutical & Biotechnology Companies 16.22.2. Academic & Research Institutes 16.22.3. Contract Research Organizations 16.23. South Africa Custom Antibody Market Forecast, by Type 16.23.1. Monoclonal Antibodies 16.23.2. Polyclonal Antibodies 16.23.3. Recombinant Antibodies 16.23.4. Others 16.24. South Africa Custom Antibody Market Forecast, by Source 16.24.1. Mice 16.24.2. Rabbit 16.24.3. Other 16.25. South Africa Custom Antibody Market Forecast, by Research area 16.25.1. Oncology 16.25.2. Infectious Diseases 16.25.3. Immunology 16.25.4. Neurobiology 16.25.5. Stem Cell 16.25.6. Cardiovascular Diseases 16.25.7. Others 16.26. Rest of Middle East & Africa Custom Antibody Market Forecast, by Service 16.26.1. Antibody Development 16.26.1.1. Antigen Preparation 16.26.1.2. Immunization & Hybridoma Production 16.26.1.3. Antibody Characterization 16.26.2. Antibody Production & Purification 16.26.3. Antibody Fragmentation & Labelling 16.27. Rest of Middle East & Africa Custom Antibody Market Forecast, by End User 16.27.1. Pharmaceutical & Biotechnology Companies 16.27.2. Academic & Research Institutes 16.27.3. Contract Research Organizations 16.28. Rest of Middle East & Africa Custom Antibody Market Forecast, by Type 16.28.1. Monoclonal Antibodies 16.28.2. Polyclonal Antibodies 16.28.3. Recombinant Antibodies 16.28.4. Others 16.29. Rest of Middle East & Africa Custom Antibody Market Forecast, by Source 16.29.1. Mice 16.29.2. Rabbit 16.29.3. Other 16.30. Rest of Middle East & Africa Custom Antibody Market Forecast, by Research area 16.30.1. Oncology 16.30.2. Infectious Diseases 16.30.3. Immunology 16.30.4. Neurobiology 16.30.5. Stem Cell 16.30.6. Cardiovascular Diseases 16.30.7. Others 16.31. Middle East & Africa Custom Antibody Market Attractiveness Analysis 16.31.1. By Service 16.31.2. By End User 16.31.3. By Type 16.31.4. By Source 16.31.5. By Research area 16.32. PEST Analysis 16.33. Key Trends 16.34. Key Developments 17. South America Custom Antibody Market Analysis 17.1. Key Findings 17.2. South America Custom Antibody Market Overview 17.3. South America Custom Antibody Market Value Share Analysis, by Service 17.4. South America Custom Antibody Market Forecast, by Service 17.4.1. Antibody Development 17.4.1.1. Antigen Preparation 17.4.1.2. Immunization & Hybridoma Production 17.4.1.3. Antibody Characterization 17.4.2. Antibody Production & Purification 17.4.3. Antibody Fragmentation & Labelling 17.5. South America Custom Antibody Market Value Share Analysis, by End User 17.6. South America Custom Antibody Market Forecast, by End User 17.6.1. Pharmaceutical & Biotechnology Companies 17.6.2. Academic & Research Institutes 17.6.3. Contract Research Organizations 17.7. South America Custom Antibody Market Value Share Analysis, by Type 17.8. South America Custom Antibody Market Forecast, by Type 17.8.1. Monoclonal Antibodies 17.8.2. Polyclonal Antibodies 17.8.3. Recombinant Antibodies 17.8.4. Others 17.9. South America Custom Antibody Market Value Share Analysis, by Source 17.10. South America Custom Antibody Market Forecast, by Source 17.10.1. Mice 17.10.2. Rabbit 17.10.3. Other 17.11. South America Custom Antibody Market Value Share Analysis, by Research area 17.12. South America Custom Antibody Market Forecast, by Research area 17.12.1. Oncology 17.12.2. Infectious Diseases 17.12.3. Immunology 17.12.4. Neurobiology 17.12.5. Stem Cell 17.12.6. Cardiovascular Diseases 17.12.7. Others 17.13. South America Custom Antibody Market Value Share Analysis, by Country 17.14. South America Custom Antibody Market Forecast, by Country 17.14.1. Brazil 17.14.2. Mexico 17.14.3. Rest of South America 17.15. South America Custom Antibody Market Analysis, by Country 17.16. Brazil Custom Antibody Market Forecast, by Service 17.16.1. Antibody Development 17.16.1.1. Antigen Preparation 17.16.1.2. Immunization & Hybridoma Production 17.16.1.3. Antibody Characterization 17.16.2. Antibody Production & Purification 17.16.3. Antibody Fragmentation & Labelling 17.17. Brazil Custom Antibody Market Forecast, by End User 17.17.1. Pharmaceutical & Biotechnology Companies 17.17.2. Academic & Research Institutes 17.17.3. Contract Research Organizations 17.18. Brazil Custom Antibody Market Forecast, by Type 17.18.1. Monoclonal Antibodies 17.18.2. Polyclonal Antibodies 17.18.3. Recombinant Antibodies 17.18.4. Others 17.19. Brazil Custom Antibody Market Forecast, by Source 17.19.1. Mice 17.19.2. Rabbit 17.19.3. Other 17.20. Brazil Custom Antibody Market Forecast, by Research area 17.20.1. Oncology 17.20.2. Infectious Diseases 17.20.3. Immunology 17.20.4. Neurobiology 17.20.5. Stem Cell 17.20.6. Cardiovascular Diseases 17.20.7. Others 17.21. Mexico Custom Antibody Market Forecast, by Service 17.21.1. Antibody Development 17.21.1.1. Antigen Preparation 17.21.1.2. Immunization & Hybridoma Production 17.21.1.3. Antibody Characterization 17.21.2. Antibody Production & Purification 17.21.3. Antibody Fragmentation & Labelling 17.22. Mexico Custom Antibody Market Forecast, by End User 17.22.1. Pharmaceutical & Biotechnology Companies 17.22.2. Academic & Research Institutes 17.22.3. Contract Research Organizations 17.23. Mexico Custom Antibody Market Forecast, by Type 17.23.1. Monoclonal Antibodies 17.23.2. Polyclonal Antibodies 17.23.3. Recombinant Antibodies 17.23.4. Others 17.24. Mexico Custom Antibody Market Forecast, by Source 17.24.1. Mice 17.24.2. Rabbit 17.24.3. Other 17.25. Mexico Custom Antibody Market Forecast, by Research area 17.25.1. Oncology 17.25.2. Infectious Diseases 17.25.3. Immunology 17.25.4. Neurobiology 17.25.5. Stem Cell 17.25.6. Cardiovascular Diseases 17.25.7. Others 17.26. Rest of South America Custom Antibody Market Forecast, by Service 17.26.1. Antibody Development 17.26.1.1. Antigen Preparation 17.26.1.2. Immunization & Hybridoma Production 17.26.1.3. Antibody Characterization 17.26.2. Antibody Production & Purification 17.26.3. Antibody Fragmentation & Labelling 17.27. Rest of South America Custom Antibody Market Forecast, by End User 17.27.1. Pharmaceutical & Biotechnology Companies 17.27.2. Academic & Research Institutes 17.27.3. Contract Research Organizations 17.28. Rest of South America Custom Antibody Market Forecast, by Type 17.28.1. Monoclonal Antibodies 17.28.2. Polyclonal Antibodies 17.28.3. Recombinant Antibodies 17.28.4. Others 17.29. Rest of South America Custom Antibody Market Forecast, by Source 17.29.1. Mice 17.29.2. Rabbit 17.29.3. Other 17.30. Rest of South America Custom Antibody Market Forecast, by Research area 17.30.1. Oncology 17.30.2. Infectious Diseases 17.30.3. Immunology 17.30.4. Neurobiology 17.30.5. Stem Cell 17.30.6. Cardiovascular Diseases 17.30.7. Others 17.31. South America Custom Antibody Market Attractiveness Analysis 17.31.1. By Service 17.31.2. By End User 17.31.3. By Type 17.31.4. By Source 17.31.5. By Research area 17.32. PEST Analysis 17.33. Key Trends 17.34. Key Developments 18. Company Profiles 18.1. Market Share Analysis, by Company 18.2. Competition Matrix 18.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 18.2.2. New Product Launches and Product Enhancements 18.2.3. Market Consolidation 18.2.3.1. M&A by Regions, Investment and Applications 18.2.3.2. M&A Key Players, Forward Integration and Backward Integration 18.3. Company Profiles: Key Players 18.3.1. Thermo Fisher Scientific Inc. 18.3.1.1. Company Overview 18.3.1.2. Financial Overview 18.3.1.3. Product Portfolio 18.3.1.4. Business Strategy 18.3.1.5. Recent Developments 18.3.1.6. Company Footprint 18.3.2. Genscript Biotech Corporation 18.3.3. Abcam plc 18.3.4. Rockland Immunochemicals Inc. 18.3.5. Creative Biolabs Inc. 18.3.6. RayBiotech Inc. 18.3.7. Covance Inc 18.3.8. Bio-Rad Laboratories, Inc. 18.3.9. Merck Group 18.3.10. Cell Signaling Technology, Inc. 18.3.11. Agilent Technologies, Inc. 18.3.12. BioLegend, Inc. 18.3.13. ProMab Biotechnologies 19. Primary Key Insights

About This Report

Report ID34046
Published DateSept 2019
Contact Us
Call Now